Clinical trials
Terminated Nasopharyngeal Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atara Biotherapeutics | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Genmab | 1 |
| Incyte Corporation | 1 |
| Inhibrx Biosciences, Inc | 1 |
| National Cancer Institute (NCI) | 1 |
| Stanford University | 1 |
| Telix Pharmaceuticals (Innovations) Pty Ltd | 1 |
| Viracta Therapeutics, Inc. | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 10 |
| Carcinoma, Renal Cell | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Transitional Cell | 2 |
| Epstein-Barr Virus Infections | 2 |
| Head and Neck Neoplasms | 2 |
| Nasopharyngeal Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.